Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -962,472 | -962,763 | -469,229 | -733,339 | -1,076,398 |
| Depreciation Amortization | 254,820 | 106,482 | 45,090 | 322,466 | 145,807 |
| Accounts receivable | 1,172,056 | 137,359 | 548,557 | 419,530 | 1,393,853 |
| Accounts payable and accrued liabilities | -349,735 | -64,025 | -1,022,948 | 820,665 | 649,534 |
| Other Working Capital | 894,442 | 137,586 | -438,783 | 1,320,811 | 2,103,425 |
| Other Operating Activity | -837,867 | -74,583 | 514,845 | -1,925,380 | -2,478,389 |
| Operating Cash Flow | $171,244 | $-719,944 | $-822,468 | $224,752 | $737,832 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,236,888 | N/A | N/A | N/A | N/A |
| PPE Investments | -126,241 | -85,140 | -50,989 | -308,723 | -241,252 |
| Net Acquisitions | -91,759 | -89,113 | -82,700 | N/A | N/A |
| Purchase Of Investment | N/A | -4,742,525 | -2,641,862 | -13,385,900 | -11,327,530 |
| Sale Of Investment | 9,427,529 | 6,908,714 | 4,688,707 | 11,621,970 | 8,768,540 |
| Purchase Sale Intangibles | -672,118 | -649,675 | -599,652 | -179,412 | -155,374 |
| Other Investing Activity | -672,117 | -649,676 | -599,652 | -179,413 | -155,373 |
| Investing Cash Flow | $300,524 | $1,342,260 | $1,313,504 | $-2,252,066 | $-2,955,615 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10,988 | -9,309 | -4,741 | -2,489 | -2,529 |
| Other Financing Activity | -34,132 | -21,455 | -9,798 | -47,180 | -39,916 |
| Financing Cash Flow | $-45,120 | $-30,764 | $-14,538 | $-49,668 | $-42,445 |
| Exchange Rate Effect | -33,197 | -7,833 | -16,961 | 16,015 | 1,320 |
| Beginning Cash Position | 11,410,680 | 11,081,710 | 10,284,160 | 12,621,290 | 12,825,400 |
| End Cash Position | 11,797,590 | 11,657,940 | 10,729,790 | 10,563,350 | 10,583,210 |
| Net Cash Flow | $386,906 | $576,228 | $445,631 | $-2,057,938 | $-2,242,194 |
| Free Cash Flow | |||||
| Operating Cash Flow | 171,244 | -719,944 | -822,468 | 224,752 | 737,832 |
| Capital Expenditure | -130,800 | -86,275 | -51,516 | -310,022 | -241,802 |
| Free Cash Flow | 40,444 | -806,219 | -873,984 | -85,269 | 496,030 |